Celleva Inc. - Innovation in Regenerative Medicine

Celleva Inc. is a leading biotechnology company headquartered in South Korea, specializing in cutting-edge regenerative medicine. As the creator of both HELIXERA™ (advanced PN/PDRN technology) and PEXT™ (premium exosome therapy), Celleva delivers comprehensive solutions for cellular regeneration and aesthetic medicine.

Operating from state-of-the-art facilities in Goyang-si, Gyeonggi-do, Celleva combines breakthrough research in both exosome biology and DNA-based therapeutics with pharmaceutical-grade manufacturing to deliver world-class regenerative products.